Ryosuke Morimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ryosuke Morimoto has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Yuji Isegawa
Department of Applied Biological Chemistry, Graduate School of Agriculture, Osaka Metropolitan University, Sakai, Osaka 599-8531, Japan
4 shared publications Akari Hanada
Department of Food Sciences and Nutrition, School of Food Sciences and Nutrition, Mukogawa Women’s University, Nishinomiya, Japan
2 shared publicationsChiaki Matsubara
Department of Food Sciences and Nutrition, School of Food Sciences and Nutrition, Mukogawa Women’s University, Nishinomiya, Japan
2 shared publicationsHidenobu Sumitani
Toyo Institute of Food Technology, Kawanishi, Japan
2 shared publicationsTokutaro Ogata
Faculty of Parmaceutical Sciences, Hokuriku University, Kanazawa, Japan
2 shared publicationsYuka Horio
Department of Food Sciences and Nutrition, School of Food Sciences and Nutrition, Mukogawa Women’s University, Nishinomiya, Japan
2 shared publications
Latest Publications
- Open Access
Anti-Influenza Virus Activity of Citrullus lanatus var. citroides as a Functional Food: A Review
Influenza is an acute respiratory illness caused by the influenza virus, in response to which vaccines and antiviral drugs are administered. In recent years, the antiviral effects of plants and foods have garnered attention. This review is the first to summarize the therapeutic properties of wild watermelon (Citrullus lanatus var. citroides) against influenza from a phytochemical viewpoint. Wild watermelon is a wild plant with significant potential as a therapeutic candidate in antiviral strategies, when focused on its multiple anti-influenza functionalities. Wild watermelon juice inhibits viral growth, entry, and replication. Hence, we highlight the possibility of utilizing wild watermelon for the prevention and treatment of influenza with stronger antiviral activity. Phytochemicals and phytoestrogen (polyphenol, flavonoids, and prenylated compounds) in wild watermelon juice contribute to this activity and inhibit various stages of viral replication, depending on the molecular structure. Wild plants and foods closely related to the original species contain many natural compounds such as phytochemicals, and exhibit various viral growth inhibitory effects. These natural products provide useful information for future antiviral strategies.
Open AccessAnti-Influenza Virus Activity of Citrullus lanatus var. citroides as a Functional Food: A Review
Influenza is an acute respiratory illness caused by the influenza virus, in response to which vaccines and antiviral drugs are administered. In recent years, the antiviral effects of plants and foods have garnered attention. This review is the first to summarize the therapeutic properties of wild watermelon (Citrullus lanatus var. citroides) against influenza from a phytochemical viewpoint. Wild watermelon is a wild plant with significant potential as a therapeutic candidate in antiviral strategies, when focused on its multiple anti-influenza functionalities. Wild watermelon juice inhibits viral growth, entry, and replication. Hence, we highlight the possibility of utilizing wild watermelon for the prevention and treatment of influenza with stronger antiviral activity. Phytochemicals and phytoestrogen (polyphenol, flavonoids, and prenylated compounds) in wild watermelon juice contribute to this activity and inhibit various stages of viral replication, depending on the molecular structure. Wild plants and foods closely related to the original species contain many natural compounds such as phytochemicals, and exhibit various viral growth inhibitory effects. These natural products provide useful information for future antiviral strategies.
- Open Access
- 13 December 2022
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 77 (1) , 228-229
Correction: Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship
- 13 December 2022
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 77 (1) , 228-229
Open AccessCorrection: Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship
- Open Access
- 28 November 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (12) , 1480
Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones
Vaccines and antiviral drugs are widely used to treat influenza infection. However, they cannot rapidly respond to drug-resistant viruses. Therefore, new anti-influenza virus strategies are required. Naringenin is a flavonoid with potential for new antiviral strategies. In this study, we evaluated the antiviral effects of naringenin derivatives and examined the relationship between their cellular uptake and antiviral effects. Madin–Darby canine kidney (MDCK) cells were infected with the A/PR/8/34 strain and exposed to the compound-containing medium for 24 h. The amount of virus in the supernatant was calculated using focus-forming reduction assay. Antiviral activity was evaluated using IC50 and CC50 values. Cells were exposed to a constant concentration of naringenin or prenylated naringenin, and intracellular uptake and distribution were evaluated using a fluorescence microscope. Prenylated naringenin showed strong anti-influenza virus effects, and the amount of intracellular uptake was revealed by the strong intracellular fluorescence. In addition, intracellular distribution differed depending on the position of the prenyl group. The steric factor of naringenin is deeply involved in influenza A virus activity, and prenyl groups are desirable. Furthermore, the prenyl group affects cellular affinity, and the uptake mechanism differs depending on its position. These results provide important information on antiviral strategies.
- 28 November 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (12) , 1480
Open AccessEffect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones
Vaccines and antiviral drugs are widely used to treat influenza infection. However, they cannot rapidly respond to drug-resistant viruses. Therefore, new anti-influenza virus strategies are required. Naringenin is a flavonoid with potential for new antiviral strategies. In this study, we evaluated the antiviral effects of naringenin derivatives and examined the relationship between their cellular uptake and antiviral effects. Madin–Darby canine kidney (MDCK) cells were infected with the A/PR/8/34 strain and exposed to the compound-containing medium for 24 h. The amount of virus in the supernatant was calculated using focus-forming reduction assay. Antiviral activity was evaluated using IC50 and CC50 values. Cells were exposed to a constant concentration of naringenin or prenylated naringenin, and intracellular uptake and distribution were evaluated using a fluorescence microscope. Prenylated naringenin showed strong anti-influenza virus effects, and the amount of intracellular uptake was revealed by the strong intracellular fluorescence. In addition, intracellular distribution differed depending on the position of the prenyl group. The steric factor of naringenin is deeply involved in influenza A virus activity, and prenyl groups are desirable. Furthermore, the prenyl group affects cellular affinity, and the uptake mechanism differs depending on its position. These results provide important information on antiviral strategies.
- 11 November 2022
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 77 (1) , 219-227
Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship
- 11 November 2022
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 77 (1) , 219-227
Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship